Fukutake Toshio
Department of Neurology, Kameda Medical Center.
Brain Nerve. 2020 Dec;72(12):1371-1381. doi: 10.11477/mf.1416201695.
Hirayama disease is a rare and self-limiting cervical myelopathy related to neck flexion in adolescents, predominantly male, originally described by Hirayama in 1959 and until today reported worldwide. It characteristically presents with asymmetric distal upper extremity muscular weakness and atrophy without objective sensory disturbance or lower extremity involvement, which spontaneously halts within 3-5 years after onset with some sequelae. Neuroradiological and autopsy/neuropathological studies have shown that the condition is caused by chronic ischemic changes to the anterior horn cells of the lower cervical cord due to abnormal forward-shifting of the lower cervical posterior dura on neck flexion. Although the true pathomechanism of the dural changes is still unknown, various hypothetical theories have been formulated: "tight dural canal in flexion", "flexion myelopathy", "engorgement of the posterior venous plexus", and "disproportional growth between the vertebral column and the contents of the spinal canal during puberty" (Hirayama). However, rarity of the condition and asymmetric cord involvement cannot be explained with these theories alone. Combination of a "posterior epidural ligament [sparse at C6-C7] factor" proposed by Shinomiya , "loss of dorsal dural attachment from the pedicle even in neutral position in the MRI" pointed out by some neuroradilogists, and "pathological abnormalities of elastic and collagen fibers in the operatively-resected dura" reported by several spinal surgeons suggest that abnormal changes of the dura and posterior ligaments, as well as the existence of "myodural bridge" at C1-C2 described by some neuroanatomists, can cause the dural forward-shifting of the lower cervical cord. In addition to these mechanical factors, immunological abnormalities such as hyperIgEemia and upreguration of some cytokines and chemokines in serum/CSF of patients with Hirayama disease have been reported. Furthermore, immune cells comprise -17% of all cells in the dura in rats. In conclusion, although further immunological studies of the patient's cervical dura and surrounding structures are required, I propose, in addition to Hirayama's theory, a new hypothesis about the pathomechanism of Hirayama disease, "loss of dorsal dural attachment from the pedicle due to immunological abnormalities of the dura and posterior ligaments", which can resolve the remaining problems of the condition. (Received May 25, 2020; Accepted July 2, 2020; Published December 1, 2020).
平山病是一种罕见的、自限性的青少年颈椎脊髓病,与颈部屈曲有关,多见于男性,最初由平山于1959年描述,至今在全球范围内均有报道。其典型表现为不对称的上肢远端肌肉无力和萎缩,无客观感觉障碍或下肢受累,发病后3 - 5年内可自发停止,但会遗留一些后遗症。神经放射学及尸检/神经病理学研究表明,该病是由于颈部屈曲时下颈段硬脊膜异常向前移位,导致下颈髓前角细胞发生慢性缺血性改变所致。尽管硬脊膜改变的真正发病机制仍不清楚,但已提出了各种假说:“屈曲时硬脊膜管狭窄”“屈曲性脊髓病”“后静脉丛充血”以及“青春期脊柱与椎管内容物生长比例失调”(平山病)。然而,仅凭这些理论无法解释该病的罕见性及脊髓不对称受累的情况。Shinomiya提出的“后硬膜外韧带[C6 - C7处稀疏]因素”、一些神经放射学家指出的“MRI显示即使在中立位时硬脊膜与椎弓根的背侧附着也缺失”以及几位脊柱外科医生报道的“手术切除的硬脊膜中弹性纤维和胶原纤维的病理异常”表明,硬脊膜和后韧带的异常改变以及一些神经解剖学家描述的C1 - C2处“肌硬膜桥”的存在,可导致下颈髓硬脊膜向前移位。除了这些机械因素外,还报道了平山病患者血清/脑脊液中存在高IgE血症以及一些细胞因子和趋化因子上调等免疫异常情况。此外,大鼠硬脊膜中免疫细胞占所有细胞的-17%。总之,尽管需要对患者的颈段硬脊膜及周围结构进行进一步的免疫学研究,但我提出,除了平山病理论外,关于平山病发病机制的一个新假说——“由于硬脊膜和后韧带的免疫异常导致硬脊膜与椎弓根的背侧附着缺失”,这一假说可以解决该病遗留的问题。(2020年5月25日收稿;2020年7月2日接受;2020年12月1日发表)